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Introduction
!
With the widespread introduction of population
screening for colorectal cancer (CRC), the number
of early CRCs is expected to increase [1–6]. In the
past, approximately 25% of CRC cases presented
with early disease (stage I) in which the primary
tumor is limited to the submucosa (T1 tumors)
or the bowel wall (T2 tumors). Local excision is
an attractive option for early disease in both colon
and rectal cancer, as it is associated with consid-
erably less surgery-related morbidity and almost
no postoperative mortality comparedwith colect-
omy and total mesorectal excision (TME) [7–13],
for which mortality rates of 1.9%–6.5% (rectum)
and 3.2%–9.8% (colon) have been reported [14,
15].
Clinically, local treatment is especially relevant
for rectal cancer, as the consequences of TME sur-
gery, which often results in a colostomy, sexual
and urinary dysfunction, and complaints of soil-
ing and fecal incontinence, are greater than for
colectomy [16–20]. Moreover, the removal of tu-
mors in the rectum, using transanal endoscopic
microsurgery (TEM) and endoscopic submucosal
dissection (ESD), is more effective than in the co-
lon, where ESD is technically difficult and where
mainly polypectomy and endoscopic mucosal re-
section (EMR) are used [13,21]. However, there is
a considerable move towards organ-preserving
surgery for colon cancer as well, as techniques
for local treatment in the colon are improving
[22].
Local excision is generally reserved for T1 disease,
as adequate removal of T2 tumors using ESD or
EMR in the colon is not feasible [23], and for rectal
cancer local treatment of T2 lesions is reported to
result in unacceptably high local recurrence rates
and a lower survival compared with radical resec-
tion [10,24].
Currently, patient-related factors such as age and
co-morbidity are of primary importance when
deciding whether or not to perform a radical re-
section for early CRC. For fit patients with T1
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Background and study aim: Population screening
for colorectal cancer (CRC) is expected to increase
the number of pT1 CRCs. Local excision is an at-
tractive treatment option, but is only oncological-
ly safe in the absence of lymph node metastasis
(LNM). A systematic review of the predictive val-
ue of pathological risk factors for LNM in pT1 CRC
was conducted to provide data for an evidence-
based decision regarding follow-up or radical sur-
gery after local excision.
Methods: PubMed was searched for reports on
predictors of LNM in pT1 CRC. Published papers
written in English and containing at least 50 pa-
tients were included. Meta-analyses were per-
formed using Review Manager 5.1.
Results: A total of 17 studies were included invol-
ving a total of 3621 patients with available nodal
status. The strongest independent predictors of
LNM were lymphatic invasion (relative risk [RR]
5.2, 95% confidence interval [CI] 4.0–6.8), sub-
mucosal invasion ≥1mm (RR 5.2, 95%CI 1.8–
15.4), budding (RR 5.1, 95%CI 3.6–7.3), and poor
histological differentiation (RR 4.8, 95%CI 3.3–
6.9). Limitations of the study were: results could
not be stratified according to location in the colon
or rectum; very early tumors removed by poly-
pectomy without surgical resection were not in-
cluded in the meta-analysis; and included studies
were primarily from Asian countries and results
therefore need to be verified in Western popula-
tions.
Conclusion: The absence of lymphatic invasion,
budding, submucosal invasion ≥1mm, and poor
histological differentiation were each associated
with low risk of LNM. Risk stratification models
integrating these factors need to be investigated
further.
D
ow
nl
oa
de
d 
by
: R
ad
bo
ud
 U
ni
ve
rs
ite
it 
Ni
jm
eg
en
. C
op
yri
gh
ted
 m
ate
ria
l.
CRC, the curative intent is absolute and a local excision can only
be oncologically safe in the absence of lymph node metastasis
(LNM). The overall incidence of LNM in T1 tumors is between 8%
and 16% [25–28], and several pathological features of the pri-
mary tumor, such as poor differentiation, lymphatic or vascular
invasion, and submucosal invasion depth, have been associated
with its presence [29–32].
Patient selection through careful histological analysis of local ex-
cision specimens can therefore be very useful to avoid over- and
under-treatment. For rectal cancer, some of the characteristics
mentioned above are already included in national guidelines as
indicators of high risk lesions necessitating additional radical sur-
gery (e.g. American [National Cancer Institute], British, Japanese
and Dutch national guidelines [33–36]).
However, despite the importance of high quality discrimination
between low and high risk T1 cases, an adequate overview of
the literature that quantifies the influence of the individual risk
factors, is lacking. Although the described differences regarding
treatment options and associated morbidity suggest that the
clinical relevance is currently greatest for rectal cancer, risk stra-
tification is valuable for pT1 colon cancer as well.
Unfortunately, a separate analysis is not feasible, as studies de-
scribing nodal involvement exclusively for pT1 rectal cancer are
very scarce. Therefore, the current study provides a systematic
review of the risk factors for the presence of LNM in pT1 CRC in-
cluding meta-analyses where appropriate.
Methods
!
Search strategy and selection criteria
A comprehensive literature search was performed using the
PubMed database from inception to 25 May 2011. The keywords
used were “lymph nodes,” “lymph node metastasis,” “TEM,” and
“T1” combinedwith “colorectal cancer.”Additional searcheswere
performed using manual cross-referencing. Only published stud-
ies written in English andwith at least 50 patients were included.
Reports describing use of neo-adjuvant therapy (ypT) were not
included. Radical resection was required to obtain a reliable
lymph node status. The percentage or number of patients with
nodal involvement, specified for presence and absence of a
specific risk factor, was required. Data from pT1 patients had to
be reported separately. In case of possible overlap of data due to
duplicate publications, only the article with the largest sample
size was included.
Measuring submucosal invasion depth
Various methods of dividing patients into a low or high risk
group based on submucosal invasion depth are described in
the literature. For sessile lesions a qualitative assessment ac-
cording to Kudo et al. (1993) [37] is commonly used (sm1,
sm2, and sm3: invasion into the most superficial, intermediate,
and deepest 1/3 of the submucosa, respectively). This has been
modified slightly into a semi-quantitative system by Kikuchi et
al. (1995) [32] (sm1: invasion up to 0.2–0.3mm; sm2: inter-
mediate invasion; sm3: invasion near the muscularis propria).
A third method quantifies invasion depth (sm1: up to 0.5mm;
sm2: 0.5–1.0mm; sm3: beyond 1.0mm) [38]. Alternatively, the
invasion depth is measured and a cut-off value is defined to
distinguish between superficial and deep submucosal invasion.
For the purpose of performing the current meta-analysis, the
studies were divided into two groups: one group included stud-
ies using a quantitative invasion depth and the other included
studies using qualitative or semi-quantitative invasion depth.
Statistical analysis
Datawere extracted and analyzed by a single investigator (S.L.B.).
For all studies in the meta-analysis the frequencies of LNM per
factor were available either from the text or from tables. Risk fac-
tors, incidence, and events from the individual studies were en-
tered into Review Manager 5.1 (RevMan, Copenhagen: The Nor-
dic Cochrane Centre, The Cochrane Collaboration, 2011). If a fac-
tor was reported in at least three studies with comparable meth-
odology, a meta-analysis was performed to summarize its prog-
nostic effect in terms of a relative risk (RR) with 95% confidence
interval (CI). A random effects model with Mantel–Haenszel
weighting was used. Heterogeneity was assessed using a χ2 test
for heterogeneity, with a P value of <0.10 taken to reflect the
presence of significant heterogeneity. The I2 statistic was calcu-
lated to quantify the degree of heterogeneity. Publication bias
was assessed by inspection of the funnel plot by an experienced
statistician (S.T.). Data presented as pooled estimates do not ac-
count for heterogeneity between studies and are reported for ex-
plorative purposes only.
Results
!
Study selection and inclusion
The initial search returned a total of 43 studies (●" Fig.1). Follow-
ing review, 32 potentially relevant studies were identified as eli-
gible of which 12 were excluded for duplicate series of patients,
and 2 [32, 39] were excluded as they did not report separate data
for patients with a radical resection and patients with local exci-
sion only.
In three studies [40–42], patients who underwent local excision
only were reported separately and only the patients who receiv-
ed radical resection were included in the current analyses. An-
other study was excluded, because of a major discrepancy be-
tween data reported in text and tables [43]. Repeated attempts
to contact the authors by email to clarify this issue were unsuc-
cessful. Therefore, the data from this study were assumed to be
unreliable.
The 17 studies selected for this review [28,38,40–42,44–55]
included a total of 3782 patients with pT1 tumors. A total of
1561 patients had rectal carcinomas (41.3%), 2080 patients had
colon carcinomas (55.0%), and in 141 patients no distinction
was made between colon and rectal carcinomas (3.7%). A total
of 3621 patients had available nodal status after radical resection
and only these patients were included in the meta-analysis. The
median number of patients per study was 140 (range 65–865).
●" Table1 outlines the characteristics of these studies. The inci-
dence of LNM was 11.4% (414/3621). Of the included studies, 2
were performed prospectively and 15 were retrospective studies.
Publication bias and heterogeneity
Inspection of the funnel plots (●" Fig.e2, available online) did not
reveal asymmetry, therefore there was no indication of publica-
tion bias. However, the funnel plot analysis was limited in many
cases by the low number of studies. Forest plots (●" Fig.e3–e8,
available online) were checked for consistency of the effects.
There was only quantitative heterogeneity.
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Factors predicting LNM
Factors that were investigated in at least three studies with com-
parable methodology were included in the meta-analyses. These
factors are depicted in●" Fig.9 and include tumor location, lym-
phatic, vascular and lymphovascular invasion, submucosal inva-
sion depth (based on sm-levels, cut-off value 1mm and cut-off
value 2mm), width of submucosal invasion (cut-off 5mm), histo-
logical differentiation grade (high grade vs. low grade), budding,
and poor differentiation at the invasion front. Forest plots gener-
ated for the analysis of each individual risk factor are included in
●" Fig.e3–e8 (available online).
●" Table2 provides the data for the dichotomous risk factors with
total number of patients available for each analysis, the calculat-
ed relative risks for presence of LNM, and the level of heterogene-
ity. The data for submucosal invasion depth based on the three-
tiered sm-levels (see Methods section) are shown in●" Table3.
For all relevant factors the corresponding sensitivity, specificity,
positive predictive value, and negative predictive value are in-
cluded in●" Table4.●" Tablee5 (available online) shows the re-
sults of the multivariable analyses in the different studies. For
submucosal invasion depth themethodology differs considerably
between the studies.
Lymphatic, vascular, and lymphovascular invasion
Most studies included lymphatic or vascular (sometimes called
venous) invasion either as separate variables or gathered under
the heading of lymphovascular invasion. Definitions were not of-
ten provided, with the exception of Tsuruta et al. ([54]) andWang
et al. [55], where lymphatic invasion was defined as tumor cells
in a space covered with endothelial cells in the absence of ery-
throcytes. Blood vessel invasion was defined as tumor within a
space lined with either smooth muscle or endothelium with ad-
ditional fibrin clots, erythrocytes or both without erythrocyte ex-
travasation into the surrounding tissue [55]. Lymphovascular in-
vasion was defined by Okabe et al. [51] as the presence of tumor
cells within an epithelium-lined channel thought to represent ei-
ther a lymphatic vessel or a blood vessel.
Additional staining techniques such as Victoria blue [46,53] and
Elastica von Gieson (EVG) [44,45,54] or immunohistochemical
stains such as D2–40 [45], LYVE-1 [46], vWF [46], and CD34
[42] were used by some authors.
Lymphatic invasion was the most powerful predictor of LNM
emerging from the meta-analyses (RR 5.2 [95%CI 4.0–6.8]). Mul-
tivariable analyses also provide solid evidence for an indepen-
Table 1 Study characteristics.
First author [ref] Year Location Type of study N LNM+, n (%) Rectum, n (%) Male, n (%) Mean age
(range/±SD)
Haggitt [41] 1985 Tennessee, USA Single center 441 1292 4 (9.1) 42 (32.6)4 56 (43.4)4 63 (29–90)
Kitamura [28] 1997 Kyoto, Japan Single center 90 7 (7.8) 38 (42.2) 53 (58.9) u/k
Tsuruta [54] 2000 Kurume, Japan Single center 77 13 (16.9) 16 (20.8) 56 (72.7) 63 (±10)
Oh-e [50] 2001 Hiroshima, Japan Single center 254 35 (13.8) 92 (36.2) u/k u/k
Nascimbeni [49] 2002 Rochester, USA Single center 353 46 (13.0) 119 (33.7) 204 (57.8) 68 (36 –95)]
Suzuki [53] 2003 Kanagawa, Japan Single center 65 11 (16.9) 23 (35.4) u/k u/k
Egashira [44] 2004 Osaka, Japan Single center 140 13 (9.3) u/k u/k u/k
Kitajima [47] 2004 Tochigi, Japan Multicenter 865 87 (10.1) 350 (40.5) 514 (59.4) 63 (±11)
Okabe [51] 2004 New York, USA/
Tokyo, Japan
Multicenter3 428 43 (10.0) 176 (41.1) 258 (60.3) 64 (26–89)
Ueno [42] 2004 Saitama, Japan Single center 2511 2922 33 (13.1) 114 (39.0)4 174 (59.6)4 62 (32–91)
Yamamoto [38] 2004 Tokyo, Japan Single center 301 19 (6.3) 85 (28.2) 218 (72.4) u/k
Endreseth [40] 2005 Trondheim,
Norway
Multicenter3 2561 2912 29 (11.3) 291 (100)4 159 (54.6)4 u/k
Wang [55] 2005 Taiwan Single center 159 16 (10.1) 75 (47.2) 107 (67.3) 65 (18 –89)
Masaki [48] 2006 Tokyo, Japan Single center 76 5 (6.6) 20 (26.3) 51 (67.1) 68 (40–87)
Ishikawa [46] 2008 Tokyo, Japan Multicenter,
case-control
71 28 (39.4) 27 (38.0) 48 (67.6) u/k
Rasheed [52] 2008 St Marks, UK Single center 55 7 (12.7) 55 (100) 33 (60.0) u/k
Ishii [45] 2009 Shizuoka, Japan Single center 136 18 (13.2) 38 (27.9) 82 (60.3) 65 (29–91)
LNM, lymph node metastasis; u/k, unknown. All studies are retrospective, unless stated otherwise.
1 Cases with available nodal status
2 Total no.of cases.
3 Prospective studies.
4 All studies are retrospective, unless stated otherwise.
Excluded
▪Inadequate sample size (n = 6)
▪Data on pT1 cases not reported separately (n = 5)
Excluded
▪Duplicate series (n = 12) 
Excluded from meta-analysis
▪ Patients with local excision only who could not be
 analyzed separately (n = 2)
▪Data deemed unreliable (n = 1) 
Studies identified in initial search (n = 43)
Potentially eligible studies for further evaluation (n = 32)
Potentially appropriate studies to be included in the meta-analysis (n = 20)
Studies included in the meta-analysis (n = 17)
Fig.1 Flow chart illustrating study selection process.
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dent effect. It is important to report lymphatic invasion and vas-
cular/venous invasion separately, as vascular invasion is a much
weaker predictor of LNM (RR 2.2 [95%CI 1.4–3.2]). Combining
the two factors as lymphovascular invasion logically generates
an intermediate relative risk (RR 3.9 [95%CI 2.7–5.6]), which is
less informative. Additional staining techniques increased inter-
observer agreement for lymphatic invasion from fair in hematox-
ylin and eosin (H&E)-stained slides (κ=0.30) to moderate (κ=
0.56) in D2–40-stained slides, and for vascular invasion from
considerable for H&E slides (κ=0.10), with marked improvement
after EVG staining (κ=0.48) [56].
Tumor budding
Budding, which is also called “sprouting” or “single cell infiltra-
tion,” was reported in seven studies [42,44,46,47,51,54,55] to-
taling 1991 patients. The various authors did not use a uniform
definition; however, budding is usually described as foci of isolat-
ed cancer cells or clusters of fewer than five cancer cells at the in-
vasive front of the lesion. Ueno et al. [42] regarded five or more of
these foci in amicroscopic field at ×200magnification as positive,
whereas Ishikawa et al. [46] required more than four foci at a
magnification of ×400. Other authors did not provide a cut-off
value. Interestingly, the use of various definitions and cut-off val-
ues did not result in significant heterogeneity in the meta-analy-
sis (χ2=7.54, P=0.27, I2=20%;●" Table2). The relative risk was
strongly increased in the presence of budding (RR 5.1 [95%CI
3.6–7.3]), and five out of six studies showed an independent pre-
dictive value.
Submucosal invasion depth: qualitative or quantitative
measurement
In this meta-analyses, studies that evaluated submucosal inva-
sion depth for sessile lesions were divided into two groups con-
sisting of the ones applying a qualitative or semi-quantitative de-
finition [49,52,54,55] and those applying a strictly quantitative
definition for submucosal invasion [38,42,47,48,50,51]. Al-
though the studies by Masaki et al. [48] and Yamamoto et al.
[38] used the designations sm1, sm2, and sm3, they were includ-
ed in the quantitative group because they defined sm levels ac-
cording to a specific invasion depth in mm. In both groups, sub-
mucosal invasion depth was strongly associatedwith risk of LNM.
Increasing semi-quantitatively determined invasion depth was
associated with increased risk of LNM (sm1/2 vs. sm3, RR 3.3
[95%CI 1.8–6.2]); sm1 vs. sm2/3, RR 3.6 [95%CI 1.3–9.8])
(●" Table3). However, an independent value was only shown in
1 of 3 multivariable tests (sm1 vs. sm3, Nascimbeni et al. [49]).
In the current meta-analysis there was a significant difference
between sm2 and sm3 (RR 2.7 [95%CI 1.6–4.4]), but only a trend
for sm1 vs. sm2 (RR 2.4 [95%CI 0.9–6.1]; P=0.08) (●" Fig.e8).
For specimens lacking a muscularis propria layer, quantitative
measurement of the invasion depth from the muscularis mucosa
to the deepest part of invasion was an alternative. An invasion
depth of ≥1mm into the submucosa showed a strong increase in
relative risk for LNM (RR 5.2 [95%CI 1.8–15.4]), and was an inde-
pendent predictive factor in 2 out of 3 multivariable analyses.
Additional histological factors
Several additional histological factors were evaluated; however, a
meta-analysis was not justified in these cases because of a small
number of studies, use of varying definitions and classifications,
or lack of relevant data. These factors included submucosal inva-
sion depth according to Haggitt levels for polypoid lesions, tumor
size, histological tumor type, presence of inflammatory infiltrate,
growth pattern, a cribriform subtype, microvessel density, and
macroscopic tumor type.
Discussion
!
Published data of 3621 patients with pT1 CRC and available nodal
status following radical resection were included in this systema-
tic review. The tumor-related factors that showed the strongest
independent predictive value for LNM were lymphatic invasion,
budding, poor histological differentiation, and a submucosal in-
vasion depth ≥1mm. As the most important principle for all fit
patients with a pT1 CRC is therapy with curative intent, focus
should be on selecting patients who have a very low risk and
can safely be spared radical surgery.
Several issues need to be resolved before such selection proce-
dures can be performed safely. Standards should be set for histo-
logical characteristics in order to improve reproducibility. Appro-
priate cut-off levels for several factors should be established, and
risk stratification models applying a combination of risk factors
should be evaluated to establish the optimal combination of pre-
dictive factors. Standardization starts with the use of specific de-
finitions. The results for the predictive value of lymphatic inva-
sion illustrate this. Although lymphatic invasion is a strong and
reproducible predictive factor for LNM, especially when deter-
mined by specific antibody staining [56], the combination with
vascular invasion results in an intermediate relative risk, which
is not informative enough for clinical treatment decisions. Simi-
larly, histological differentiation is well known for its interobser-
Lymphatic invasion
Submucosal invasion depth (cut-off 1 mm)
Budding
High vs. low grade histology
Lymphovascular invasion
Submucosal invasion depth (sm1 vs. sm 2/3)
Submucosal invasion depth (sm1/2 vs. sm 3)
Submucosal width of invasion (cut-off 5 mm)
Poor differentiation at invasive front
Submucosal width of invasion (cut-off 2 mm)
Vascular invasion
Tumor location
0.1 1 10 100
Fig.9 Forest plot summarizing effect sizes of ana-
lyzed risk factors.
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ver variation [57,58], although the current classification inwhich
low grade and high grade tumors are distinguished has improved
reproducibility [59]. In the current study, poor histological differ-
entiation or high grade carcinoma was indeed a strong predictor
of LNM, with confirmation in 4 out of 10 multivariable analyses.
Budding was a relatively new and not routinely reported risk fac-
tor that consistently showed a strong association with the pres-
ence of LNM. However, many different definitions were used
throughout the literature and there was limited evidence for re-
producibility [60]. However, the strong result from the meta-a-
nalysis, which lacked significant heterogeneity, indicated that
budding, evaluated by any method, is still a powerful marker for
LNM.
Establishing cut-off levels is especially important in the determi-
nation of submucosal invasion depth. Although semi-quantita-
tive methods have proven to be useful in subsets of tumors in
the literature, their value in daily practice might be more limited.
Especially in endoscopically resected specimens, the muscularis
propria is often missing and the involved proportion of the sub-
mucosal layer is therefore hard to estimate. Quantitative meas-
urement of the invasion depth from the muscularis mucosa to
the deepest part of invasion is a more feasible method, although
the muscularis mucosa may not always be identifiable due to tu-
mor overgrowth [42]. On the other hand, an invasion depth of
more than 1mm into the submucosa showed a strong increase
in relative risk for LNM (RR 5.2 [95%CI 1.8–15.4]), and was an in-
dependent predictive factor in 2 out of 3 multivariable analyses,
suggesting it could be a helpful tool for risk stratification. Indeed,
assuming the pooled data are representative for clinical practice,
a 1-mm cut-off point would assign LNM-positive patients to the
high risk group with a sensitivity of 96.7%. However, this would
be at the expense of a low specificity (24.1%) resulting in a high
number of patients undergoing unnecessary surgery (false posi-
tives). A 1-mm cut-off may therefore not be the optimal method
for risk stratification.
As becomes clear from●" Table4, no single predictor discussed in
this review allows an optimal selection of low-risk patients by it-
self, as they are either not sensitive or not specific enough. It
therefore seems sensible to investigate the potential of combin-
ing risk factors in algorithms in order to identify low risk pa-
tients.
Ueno et al. [42] investigated several combinations of risk factors
and identified a low risk group, defined by absence of unfavor-
able grade, lymphovascular invasion, and budding, which con-
tained 55% of patients and was associated with only 0.7% nodal
involvement. The addition of submucosal depth of invasion ≥2
mm as a high risk factor eliminated nodal involvement in the
low risk group, but also decreased the percentage of low risk pa-
tients to 32.3%.
Table 3 Submucosal invasion levels and nodal involvement.
Comparison1 Low risk
group
LNM+/total LNM+, % High risk
group
LNM+/total LNM+, % RR [95%CI] P value2 Heterogeneity3
sm1 vs. sm2 sm1 6/174 3.4 sm2 17/200 8.5 2.4 [0.9 –6.1] = 0.08 χ2 = 1.01
P =0.8
I2 = 0%
sm2 vs. sm3 sm2 17/200 8.5 sm3 59/261 22.6 2.7 [1.6–4.4] < 0.001 χ2 = 2.08
P =0.56
I2 = 0%
sm1 vs. sm3 sm1 6/174 3.4 sm3 59/261 22.6 4.8 [1.5 –16.2] = 0.01 χ2 = 6.10
P =0.11
I2 = 51%
sm1 vs. sm2/3 sm1 6/174 3.4 sm2/3 76/461 16.5 3.6 [1.3 –9.8] = 0.01 χ2 = 4.40
P =0.22
I2 = 32%
sm1/2 vs. sm3 sm1 /2 23/374 6.1 sm3 59/261 22.6 3.3 [1.8–6.2] < 0.001 χ2 = 4.90
P =0.18
I2 = 39%
CI, confidence interval; LNM, lymph node metastasis; RR, relative risk.
1 Data are presented as pooled estimates and relative risks with associated heterogeneity. Data are extracted from four studies (refs. [49,52,54,55]), with a total of 635 patients.
2 P value of effect size.
3 P value for heterogeneity.
Table 4 Nodal involvement:
Sensitivity, specificity, positive
predictive value, and negative
predictive value for the identified
histological risk factors.
Factor Sensitivity, % Specificity, % PPV, % NPV, %
Tumor location in rectum 45.5 63.4 13.8 90.1
Lymphatic invasion + 69.5 73.8 26.7 94.6
Vascular invasion + 33.9 82.3 20.8 90.1
Lymphovascular invasion + 49.3 79.1 22.0 92.8
Submucosal invasion depth≥1mm 96.7 24.1 12.3 98.5
Submucosal invasion depth≥2mm 84.2 33.6 13.3 94.6
Submucosal width of invasion ≥5mm 85.2 37.3 17.0 94.4
High grade histology 22.4 92.0 24.5 91.1
Budding 74.7 63.4 21.3 95.0
Poor differentiation at invasive front 30.2 82.8 19.2 89.8
sm2/3 (vs. sm1) 92.7 30.4 16.8 96.6
sm3 (vs. sm1/2) 72.0 63.5 22.6 93.9
NPV, negative predictive value; PPV, positive predictive value.
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In a paper by Nakadoi et al. [61], the authors employed the high
risk factors described in the 2010 guidelines of the Japanese So-
ciety for Cancer of the Colon and Rectum [36], which are very
similar to the ones used by Ueno et al. [42]. They found that
when a tumor was low risk (well/moderately differentiated, no
vascular invasion or tumor budding) the incidence of LNM was
only 1.2% with 49.9% of patients assigned to the low risk group.
A limitation of the current study is that it was not possible to in-
vestigate combinations of factors. Another inevitable source of
bias is that this systematic review only included tumors from pa-
tients who underwent radical surgery. The population of patients
with early T1 cancers that were removed by polypectomy with-
out radical surgery was not included in the current analysis be-
cause the definitive lymph node status was not available. This
omission is especially relevant for pedunculated lesions, which
undergo local excision more frequently [42], and are known to
have a low risk of LNM [47]. Future studies should take this into
account.
Furthermore, the majority of papers included in this study origi-
nated from Asian countries in which pathological work-up may
be more extensive, and which might influence results. Validation
of the currently identified risk factors in Western populations is
necessary.
In conclusion, several factors can be identified in pT1 tumors that
predict the presence of LNM. Lymphatic invasion, budding, sub-
mucosal invasion depth ≥1mm, and poor histological differentia-
tion are the strongest predictors of LNM that also show a consis-
tent independent predictive value in multivariable analyses.
Their absence indicates a low risk of LNM and may justify a con-
servative policy. Future studies should investigate all of the
above-mentioned factors and aim to standardize the detection
of these powerful markers, preferably using immunohistochem-
ical staining techniques. These recommendations may lead to the
development of a validated model incorporating various risk fac-
tors for the prediction of LNM, which may help to select patients
who can be spared radical resection, and such a model may
thereby prevent unnecessary surgery without compromising on-
cological safety.
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